All In Biotech

Drug Trial Radar · NCT07662798

A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants

A Phase 1, Open-label Study to Assess the Effect of Food on the Pharmacokinetics of Tersolisib Administered Under Fasted Conditions, With a High-fat Meal, and With a Low-fat Meal, in Healthy Participants

Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Jul 1, 2026

Primary completion

Sep 3, 2026

Study completion Sep 3, 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jun 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main purpose of this study is to measure how food affects the amount of tersolisib that gets into the bloodstream. Each participant will receive two single oral doses of tersolisib, one under fasted conditions and one with either a high-fat or a low-fat meal. Blood tests will be performed to investigate how the body processes the study drug under each condition. For each participant, the study will last about 9 weeks and will include a stay in the Clinical Research Unit (CRU) lasting almost a month.

Conditions

  • Healthy

Interventions

  • TersolisibDrug

    Tersolisib administered orally

  • High-fat MealOther

    High-fat Meal

  • Low-fat MealOther

    Low-fat Meal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics (PK): Maximum Concentration (Cmax) of TersolisibTime frame: Predose on Day 1 Through Day 28
  2. PK: Area Under the Concentration Versus Time Curve (AUC) of TersolisibTime frame: Predose on Day 1 Through Day 28

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Lenexa Clinic

    Lenexa, Kansas

  • ICON Early Phase Services, LLC

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.